Ligand · 4DN
4DN · 3-[{2-[(1,1-dioxido-2,3-dihydro-1,2-benzothiazol-6-yl)amino]pyrimidin-4-yl}(1H-indazol-4-yl)amino]propan-1-ol
4DN, 3-[{2-[(1,1-dioxido-2,3-dihydro-1,2-benzothiazol-6-yl)amino]pyrimidin-4-yl}(1H-indazol-4-yl)amino]propan-1-ol (C21 H21 N7 O3 S, 451.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- 4DN
- Formula
- C21 H21 N7 O3 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
4DN in 2 structures; the first of them:
- 4YJS · The kinase domain of human spleen tyrosine (syk) in complex with GTC000226 · 4DN A701 · binds LEU377, VAL385, ALA400, VAL401, LYS402, GLU420, MET424, VAL433 and 12 more
- 4YJS · The kinase domain of human spleen tyrosine (syk) in complex with GTC000226 · 4DN A701 · binds LEU377, VAL385, ALA400, VAL401, LYS402, GLU420, MET424, VAL433 and 12 more
Residues it binds most
LEU 2, GLU 2, MET 2, VAL 2, ALA 2, ASP 2, GLY 2, LYS 2, PRO 2, SER 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.